All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, January 29, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

3-25-Align-itero-element-5d.png

FDA OKs Align Technology’s Itero Element 5D dental scanner

March 25, 2020
By Meg Bryant
No Comments
San Jose, Calif.-based Align Technology Inc. has won the FDA’s nod for its Itero Element 5D imaging system. The company said the Itero Element 5D is the first intraoral scanner with near-infrared imaging (NIRI) technology that visualizes the internal structure of the tooth in real time. The FDA cleared the device for the detection of interproximal caries lesions above the gingiva and for monitoring the progress of such lesions.
Read More

Regulatory actions for March 25, 2020

March 25, 2020
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ArcherDX, Eurobio Scientific, Extremity Medical, Perkinelmer.
Read More

Other news to note for March 25, 2020

March 25, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Avectas, Bioiq, Biotelemetry Inc., Bluewave Technologies, Bruker, Bruker-Hain Diagnostics, Foldax, Fujifilm, Kyocera, Lumendi, Medtronic, Novacyt SA, Oblation Therapeutics, Omnipathology, PRA Health Sciences, Precision Nanosystems, Predictive Technology, Primer Design, Showa Optronics, Spok, Stemcell Technologies, T2 Biosystems, Twist Bioscience, Vycellix.
Read More

Gilead abandons orphan drug designation for COVID-19 drug

March 25, 2020
By Mari Serebrov
No Comments
Following a public backlash to Monday’s news that the FDA had granted Gilead Sciences Inc. an orphan drug designation for remdesivir, an antiviral in development to treat COVID-19, the Foster City, Calif., company is taking the unprecedented step of rescinding its request for the designation.
Read More
Bio-Europe Spring 2020

Partnering plows through a pandemic with the restaged virtual Bio-Europe Spring conference

March 25, 2020
By Karen Carey
No Comments
At the beginning of this week, the digitally-delivered Bio-Europe Spring 2020 conference launched with 6,000 partnering meetings, 45 company presentations, more than 50 virtual exhibits and 12 panel discussions scheduled.
Read More
Test tube, dropper

Proteona seals partnership for drug discovery platform and COVID-19 antibodies

March 25, 2020
By David Ho
No Comments
HONG KONG – Singapore-based Proteona Pte. Ltd. has formed a couple of significant partnerships recently, including a Germany-Singapore partnership to develop a drug screening and discovery platform using single cell multi-omics analysis for patient-derived micro-tumors, and an international alliance to develop antibodies against coronaviruses.
Read More

Regulatory front for March 25, 2020

March 25, 2020
No Comments
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Regulatory actions for March 25, 2020

March 25, 2020
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Daiichi, EMD, Exelixis, Gilead, Infinity, Intrabio, Sumitomo, Takeda, Valneva.
Read More

Other news to note for March 25, 2020

March 25, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aytu, Beigene, Biogen, Biosig, BMS, Brightinsight, Cannabics, Cansino, Celgene, Cold Genesys, Debiopharm, F. Hoffmann-La Roche, Forge, Immuron, Laekna, Lidds, Mateon, Novartis, PCI. 3B, Redhill, Repertoire, Sorrento, Stemcell, Turn, Vir, Wuxi.
Read More

In the clinic for March 25, 2020

March 25, 2020
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, Avadel, Cassava, Diffusion, Eloxx, Immutep, Lundbeck, Mind Medicine, Onconova, Opko.
Read More
Previous 1 2 … 448 449 450 451 452 453 454 455 456 … 495 496 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 27, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 27, 2022.
  • Biogen, Eisai win FDA clearance for AD therapy Leqembi

    BioWorld
    As expected, the U.S. FDA gave its go-ahead to lecanemab, an amyloid-beta binder for mild cognitive impairment caused by Alzheimer’s disease (AD) and mild AD –...
  • Stem-cells2.png

    J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM

    BioWorld
    After long years of painstaking work, the commercialization of cell and gene therapies picked up pace in 2022, with multiple approvals. More progress is expected...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing